{"id_": "1336390893121789955", "raw_data": {"created_at": "Tue Dec 08 19:23:12 +0000 2020", "id": 1336390893121789955, "id_str": "1336390893121789955", "full_text": "Wenn Ergebnisse mRNA Impfstoffe nicht so überragend wären würden wir Oxford/Astra Impfstoff als Durchbruch feiern. Ich hoffe, dass low dose Konzept kann Wirksamkeit 90% belegen. Dieser Impfstoff ist für die Welt bisher der wichtigste, weil erschwinglich https://t.co/hjFiccRYm4", "truncated": false, "display_text_range": [0, 277], "entities": {"hashtags": [], "symbols": [], "user_mentions": [], "urls": [{"url": "https://t.co/hjFiccRYm4", "expanded_url": "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext", "display_url": "thelancet.com/journals/lance…", "indices": [254, 277]}]}, "source": "<a href=\"http://twitter.com/download/iphone\" rel=\"nofollow\">Twitter for iPhone</a>", "in_reply_to_status_id": null, "in_reply_to_status_id_str": null, "in_reply_to_user_id": null, "in_reply_to_user_id_str": null, "in_reply_to_screen_name": null, "user_id": 3292982985, "user_id_str": "3292982985", "geo": null, "coordinates": null, "place": null, "contributors": null, "is_quote_status": false, "retweet_count": 62, "favorite_count": 1048, "reply_count": 78, "quote_count": 8, "conversation_id": 1336390893121789955, "conversation_id_str": "1336390893121789955", "favorited": false, "retweeted": false, "possibly_sensitive": false, "possibly_sensitive_editable": true, "card": {"name": "summary", "url": "https://t.co/hjFiccRYm4", "card_type_url": "http://card-type-url-is-deprecated.invalid", "binding_values": {"vanity_url": {"type": "STRING", "string_value": "thelancet.com", "scribe_key": "vanity_url"}, "domain": {"type": "STRING", "string_value": "www.thelancet.com"}, "title": {"type": "STRING", "string_value": "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim..."}, "description": {"type": "STRING", "string_value": "ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials."}, "thumbnail_image_small": {"type": "IMAGE", "image_value": {"url": "https://pbs.twimg.com/card_img/1339215028659085317/G2bGwHuD?format=jpg&name=100x100_2", "width": 100, "height": 100, "alt": null}}, "thumbnail_image": {"type": "IMAGE", "image_value": {"url": "https://pbs.twimg.com/card_img/1339215028659085317/G2bGwHuD?format=jpg&name=144x144_2", "width": 144, "height": 144, "alt": null}}, "thumbnail_image_large": {"type": "IMAGE", "image_value": {"url": "https://pbs.twimg.com/card_img/1339215028659085317/G2bGwHuD?format=jpg&name=420x420_2", "width": 355, "height": 355, "alt": null}}, "thumbnail_image_x_large": {"type": "IMAGE", "image_value": {"url": "https://pbs.twimg.com/card_img/1339215028659085317/G2bGwHuD?format=png&name=2048x2048_2_exp", "width": 553, "height": 355, "alt": null}}, "thumbnail_image_color": {"type": "IMAGE_COLOR", "image_color_value": {"palette": [{"percentage": 95.68, "rgb": {"red": 255, "green": 255, "blue": 255}}, {"percentage": 2.3, "rgb": {"red": 250, "green": 200, "blue": 187}}, {"percentage": 1.02, "rgb": {"red": 129, "green": 157, "blue": 202}}, {"percentage": 0.77, "rgb": {"red": 248, "green": 165, "blue": 139}}, {"percentage": 0.23, "rgb": {"red": 139, "green": 137, "blue": 138}}]}}, "thumbnail_image_original": {"type": "IMAGE", "image_value": {"url": "https://pbs.twimg.com/card_img/1339215028659085317/G2bGwHuD?format=jpg&name=orig", "width": 553, "height": 355, "alt": null}}, "card_url": {"type": "STRING", "string_value": "https://t.co/hjFiccRYm4", "scribe_key": "card_url"}}, "card_platform": {"platform": {"device": {"name": "Swift", "version": "12"}, "audience": {"name": "production", "bucket": null}}}}, "lang": "de", "supplemental_language": null}}